The Use of a Large Electronic Health Records System to Define and Characterize a Thrombotic Thrombocytopenic Purpura Population

被引：0
|
作者：
Bevan, Andrew [1 ]
Donahue, Elizabeth [2 ]
Pelloso, Luis Arthur [3 ]
Rose, Virgil [4 ]
机构：
[1] Thermo Fisher Sci, PPD, Peri & Post Approval Studies & Real World Evidenc, Cambridge, England
[2] Thermo Fisher Sci, PPD, Peri & Post Approval Studies & Real World Evidenc, Woburn, MA USA
[3] Thermo Fisher Sci, PPD, Pharmacovigilance Med & Sci Serv, Sao Paulo, Brazil
[4] Thermo Fisher Sci, PPD, Pharmacovigilance Med & Sci Serv, Morrisville, NC USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-189123
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Thrombotic thrombocytopenic purpura with severe large artery branch involvement
    Ibernon, M
    Moreso, F
    Carreras, L
    Carrera, M
    Serrano, T
    Rama, I
    Bestard, O
    Torras, J
    Poveda, R
    Grinyó, JM
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (02) : 467 - 468
  • [22] Characterizing the United Kingdom Congenital Thrombotic Thrombocytopenic Purpura Population
    Alwan, Ferras
    Vendramin, Chiara
    Liesner, Ri
    Dutt, Tina
    Clark, Amanda
    Motwani, Jayashree
    Lester, Will
    McDonald, Vickie
    Rayment, Rachel
    Cooper, Nichola
    Gooding, Richard
    Lyall, Hamish
    Biss, Tina
    van Veen, Joost
    Watson, Henry G.
    Westwood, John-Paul
    Thomas, Mari
    Scully, Marie
    BLOOD, 2017, 130
  • [23] Treatment and Characteristics of Thrombotic Thrombocytopenic Purpura in a Managed Care Population
    Wahl, Peter M.
    George, James N.
    Terrell, Deirdra R.
    Yu, Amanda
    Rodgers, Keith
    Ewenstein, Bruce
    Bohn, Rhonda L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S249 - S250
  • [24] Adolescent acquired thrombotic thrombocytopenic purpura: An analysis of the Pediatric Health Information System database
    Cohen, Clay T.
    Zobeck, Mark
    Kim, Taylor O.
    Sartain, Sarah E.
    Raffini, Leslie
    Srivaths, Lakshmi
    THROMBOSIS RESEARCH, 2023, 222 : 63 - 67
  • [25] Caplacizumab in acquired thrombotic thrombocytopenic purpura: a profile of its use
    Blair, Hannah A.
    Lyseng-Williamson, Katherine A.
    DRUGS & THERAPY PERSPECTIVES, 2019, 35 (06) : 263 - 270
  • [26] ANGIOTROPIC LARGE-CELL LYMPHOMA PRESENTING AS THROMBOTIC MICROANGIOPATHY (THROMBOTIC THROMBOCYTOPENIC PURPURA)
    SILL, H
    HOFLER, G
    KAUFMANN, P
    HORINA, J
    SPULLER, E
    KLEINERT, R
    BEHAMSCHMID, C
    CANCER, 1995, 75 (05) : 1167 - 1170
  • [27] Successful use of cyclosporine A in the treatment of refractory thrombotic thrombocytopenic purpura
    Hand, JP
    Lawlor, ER
    Yong, CKK
    Davis, JH
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 100 (03) : 597 - 599
  • [28] RATIONALE AND PROPOSAL FOR USE OF PROSTACYCLIN IN THROMBOTIC THROMBOCYTOPENIC PURPURA THERAPY
    COCCHETTO, DM
    COOK, L
    CATO, AE
    NIEDEL, JE
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1981, 7 (01): : 43 - 51
  • [29] SUCCESSFUL USE OF AZATHIOPRINE IN 2 CASES OF THROMBOTIC THROMBOCYTOPENIC PURPURA
    CHAFIZADEH, ER
    UDDEN, MM
    CLINICAL RESEARCH, 1992, 40 (02): : A420 - A420
  • [30] Caplacizumab in acquired thrombotic thrombocytopenic purpura: a profile of its use
    Hannah A. Blair
    Katherine A. Lyseng-Williamson
    Drugs & Therapy Perspectives, 2019, 35 : 263 - 270
12345